Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
2.245
+0.185 (8.98%)
At close: Oct 6, 2025, 4:00 PM EDT
2.250
+0.005 (0.22%)
After-hours: Oct 6, 2025, 7:46 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $73.33 million as of October 6, 2025. Its market cap has increased by 50.93% in one year.
Market Cap
73.33M
Enterprise Value
62.74M
1-Year Change
50.93%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $73.33M, an increase of 11.54%. That is a compound annual growth rate of 2.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 73.33M | 21.18% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |